Introduction
Hemogl obin A1c (HbA1c) has been used for many years to assist in the monitoring and treatment of diabetes. Increased emphasis has been placed upon use of this marker as a diagnostic tool. In July 2009, an international expert committee (IEC) recommended the use of HbA1c to diagnose diabetes when HbA1c levels are ≥6.5%. 1 The American Diabetes Association formally endorsed the recommendations of the IEC in January 2010. 2 The authors cited lack of availability of HbA1c testing as a possible limitation to its use in diagnosing diabetes, especially in developing parts of the world. Hemoglobin A1c testing from samples collected by finger stick onto filter paper may increase availability in areas where venipuncture is impractical. With this technique, self-collection is also possible and has been shown to improve patient satisfaction. 3 A variety of methods for HbA1c analysis of dried blood spot (DBS) samples have been described in the literature, including affinity chromatography, 4 ion-exchange chromatography, 5 and immunoturbidimetric methods. 6, 7 This article describes use of an immunoturbidimetric technique to measure HbA1c in samples collected and dried on filter paper.
Methods

Whole Blood Samples
All whole blood samples were obtained by venipuncture and collected in ethylenediaminetetraacetic acid-preserved collection tubes. Samples used for studies were selected from specimens submitted for routine testing in our laboratory.
Preparation of DBS Samples
Filter paper used for these studies was Ahlstrom 226 (ID Biological, Greenville, SC). The paper conforms to the Clinical and Laboratory Standards Institute LA4-A5 standard for use in neonatal screening programs 8 and has been approved by the Centers for Disease Control as an acceptable blood spot collection paper.
Dried blood spot samples were prepared by spotting 20 µl of whole blood onto the paper and drying at room temperature for at least 3 hours.
The National Glycohemoglobin Standardization Program (NGSP) used this method to prepare DBS samples for testing in our laboratory.
9
Roche Tina-quant ® Hemoglobin A1c II Method
The Roche Tina-quant® II assay was performed on the Hitachi Modular P analyzer. The method is based on the turbidimetric inhibition immunoassay. In the standard assay, whole blood is first hemolyzed with a hemolyzing reagent and the resulting hemolysate is added to the antibody reagent. 
Dried Blood Spot Sample Elution
Dried blood spot samples were prepared for analysis by cutting two, 1/8-inch-diameter punches from each DBS using a common paper hole punch. The punches were placed into a 12 × 75-mm test tube and eluted for 3 hours at room temperature (20-25°C) with 500 µl of Roche hemolyzing reagent. Samples were mixed gently without removing the disks, and analysis was performed directly from the test tube.
Correlation Studies
Two correlation studies were performed to evaluate the performance of DBS specimens compared to whole blood HbA1c. The first study used 73 whole blood samples with values from 3.8 to 15.3% HbA1c selected from samples submitted for routine HbA1c measurement in our laboratory. Whole blood and DBS samples were analyzed with the Tina-quant® assay system on the Hitachi Modular P analyzer. A second correlation study was performed using 40 samples with HbA1c values from 5.0 to 12.2% provided by the NGSP. Whole blood samples were tested by the NGSP using the Tosoh ion-exchange high-performance liquid chromatography (HPLC) method. DBS samples were prepared by the NGSP using the method described previously and were shipped to the laboratory for analysis by the Tina-quant® method.
To evaluate the relative performance of the DBS 
Precision Studies
Six DBS samples were prepared from whole blood with HbA1c values from 5.0 to 12.4% for within-run Tina-quant® precision studies. Five disks were punched from each DBS sample, eluted as described earlier, and tested in a single run.
Forty DBS samples, prepared by the NGSP, were used for between-run precision studies. Each sample was analyzed twice per run for 5 consecutive days. To better understand between-run precision as a function of HbA1c concentration, results were sorted by percentage HbA1c value, and the data set was segmented into four groups. Each group contained a total of 100 observations over five separate runs. Mean, standard deviation, and percentage coefficient of variance (%CV) were calculated for each group.
Stability Studies
Five whole blood samples were selected at random to study the effect of long-term storage on specimens prepared as DBS and analyzed with the Tina-quant® method. Samples stored at room temperature (20-25°C) were analyzed on day 0, 1, 2, 43, and 44.
To simulate temperature exposure and U.S. Postal Service (USPS) delivery times within the continental United States, a 9-day stability study was performed at 4, 25, and 40°C. Samples delivered to our laboratory by the USPS average 4.5 days from the date the sample was collected. Three samples were spotted onto filter paper as described previously. Samples were removed from storage on day 1, 3, 5, 7, and 9 and stored at -20°C until the end of the study. Five eluates from each sample were prepared and analyzed in a single run with the Tina-quant® method.
National Glycohemoglobin Standardization Program criteria for level II certification were used as the measure of acceptability for Tina-quant® stability studies. The 95% CI for measurements, over time, must fall within ±0.75% HbA1c of the original value on day 0.
Statistical Analysis
Statistical analysis was performed with JMP Statistical Discovery software. JMP is a product of SAS, Inc. (Cary, NC).
Results
Correlation Studies
Two correlation studies were performed to investigate the relationship between whole blood and DBS HbA1c results. The first study, shown in Figure 1 , compared 73 matched whole blood and DBS samples, analyzed for HbA1c with the Tina-quant® assay. The relationship was highly correlated with r 2 = 0.996 (y = 0.984x + 0.189, p < 0.0001). The second study, shown in Figure 2 , compared 40 whole blood and DBS samples provided by the NGSP. Whole blood samples were analyzed by the NGSP using their reference Tosoh ion-exchange HPLC method. Dried blood spot samples were analyzed using the Tina-quant® assay method. The two methods were highly correlated with r 2 = 0.970 (y = 0.998x -0.204, p < 0.0001).
Bland-Altman plots of differences between DBS and whole blood HbA1c for both correlation studies are shown in Figures 3 and 4. A mean HbA1c value of 6.66% was observed in whole blood and 6.74% in DBS samples when analyzed by the Tina-quant® method (Figure 3) . The mean difference between whole blood and DBS HbA1c was 0.08% HbA1c (±0.042, 95% CI). This difference was statistically significant (p = 0.0002). For the correlation study performed with specimens provided by the NGSP, a mean value of 8.22% HbA1c for whole blood by the Tosoh method and 8.00% HbA1c by the Tina-quant® DBS method was observed. The mean difference between the two methods ( Figure  4) was -0.22% HbA1c (±0.112, 95% CI). While the mean difference was small, it was statistically significant (p = 0.0004). To determine if the mean difference between the methods was clinically significant, MDP analysis, at the critical HbA1c values of 6.0, 6.5, and 7.0%, was performed. For the correlation study involving whole blood and DBS HbA1c by the Tina-quant® method, MDP values were calculated to be 6.09, 6.58, and 7.08%. For the correlation study using whole blood HbA1c by the Tosoh method (NGSP) and DBS HbA1c by the Tina-quant® method, MDP values were 5.79, 6.29, and 6.79%. All values and their 95% confidence limits were within the acceptability criterion of ±0.75% HbA1c. 
Precision Studies
Within-run precision studies were performed for DBS samples tested on the Tina-quant® system. The observed %CV was from 0.9 to 3.2%. This compares to the whole blood within-run %CV reported by Roche 11 of 1.8 to 2.3%.
Between-run precision for the Tina-quant® method was determined from DBS samples provided by the NGSP. Results (Table 1) show %CV values from 2.2 to 3.0% for DBS samples. This compares to between-run precision results for whole blood samples published by Roche 11 of 2.2 to 4.4%.
Stability Studies
The effect of long-term storage at room temperature (~25°C) on specimens collected as DBS and analyzed with the Tina-quant® system is shown in Figure 5 . The three samples not included in the graph had initial values of approximately 5% HbA1c and showed changes similar to graphed data. The observed change in percentage HbA1c over the 44 days of the study averaged 1.78% with a maximum change of 3.9%. All results were within the predefined acceptability criterion of ±0.75% HbA1c.
A 9-day storage study was performed at 4, 25, and 40°C with DBS samples tested with the Tina-quant® system. Figure 6 shows the mean of five observations for each sample. The average change for all samples was 2.6% with the largest observed change of 5.6%. All results were within the predefined acceptability criterion of ±0.75% HbA1c.
Discussion
Correlation results reported show good agreement between whole blood and DBS HbA1c using the Tinaquant® immunoturbidimetric method. These findings are in agreement with previously published data showing good correlation between whole blood and dried blood using the Agappe Diagnostics immunoturbidimetric system. 6 This, however, is in contrast to an earlier study 7 that found a 12% high bias for DBS HbA1c compared to whole blood using the Tina-quant® II assay system.
A negative bias (0.22% HbA1c) was observed for comparisons between whole blood tested with the Tosoh ion-exchange HPLC method and matching DBS samples tested by the Tina-quant® method. A negative bias has also been reported for the Tina-quant® method compared to the Tosoh ion-exchange method. Stability studies for DBS samples tested with the Tina-quant® system show sufficient robustness to meet the requirements for time and temperature exposure anticipated within the continental United States. These studies are consistent with previously published results showing statistically insignificant changes over a 15-day period 6 and an extensive room temperature study over a 4-week period. 12 This is in contrast to stability studies that show significant temperatureindependent increases in HbA1c values over time using an affinity chromatography method. 4 The ability to provide reliable HbA1c results from samples collected on filter paper makes testing for HbA1c more viable in developing parts of the world or in other situations where venipuncture is not an option. Correlation studies show that DBS samples tested on the Tina-quant® systems are capable of producing reliable results consistent with results obtained by conventional whole blood testing methods.
